Cambridge Nutritional SciencesFRA:RVKA EBIT per Share is €0.01 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 689 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 55.44% on this metric.
Cambridge Nutritional Sciences's EBIT per Share for the
six
months ended in Sep. 2025 was €-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was €0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 12.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Cambridge Nutritional Sciences's EBIT per Share or its related term are showing as below:
FRA:RVKA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -50 Med: 3.15 Max: 33.1
Current: 12.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cambridge Nutritional Sciences was 33.10% per year. The lowest was -50.00% per year. And the median was 3.15% per year.
FRA:RVKA's 3-Year EBIT Growth Rate is ranked better than 55.44% of 689
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs FRA:RVKA: 12.60
Cambridge Nutritional Sciences (FRA:RVKA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Cambridge Nutritional Sciences EBIT per Share Related Terms
Cambridge Nutritional Sciences EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences (FRA:RVKA) has a EBIT per Share of €0.01 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cambridge Nutritional Sciences and its competitors. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #307 out of 689 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Cambridge Nutritional Sciences' EBIT per Share too high?
Cambridge Nutritional Sciences' current EBIT per Share is €0.01. Based on the distribution chart, Cambridge Nutritional Sciences ranks #307 out of 689 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Cambridge Nutritional Sciences' EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #307 out of 689 companies for EBIT per Share. This puts Cambridge Nutritional Sciences in the upper half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current EBIT per Share is €0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current EBIT per Share of €0.01. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 30% below its estimated fair value. The current EBIT per Share is €0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current EBIT per Share is €0.01 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 